Prolira

Sector Future Health Ventures

31 januari 2022 - Investors Borski fund, ROM Utrecht Region, Holland Capital, Health Innovations and Oost NL together invest €5 million in Prolira BV, the Dutch scale up that helps hospital departments improve patient care in the field of acute brain failure (acute encephalopathy and delirium).

Brain state monitor

Actively using the patient’s brain state information is essential for making better informed medical decision and realising improved patient care with better outcomes. Prolira provides the world’s first objective brain state monitor (DeltaScan®) to hospitals, as well as data driven support that quantifies the positive impact of DeltaScan implementation in patient care protocols.

Website Prolira

Relevant artikel

Meer relevante artikelen

Nieuws

Growth capital investment for Prolira for roll-out of brain state monitoring to hospitals

4 minuten 31 januari 2022

Investors Borski fund, ROM Utrecht Region, Holland Capital, Health Innovations and Oost NL together invest €5 million in Prolira ...